| Literature DB >> 33355208 |
Jiil Chung1,2,3, Yosef E Maruvka4,5, Gad Getz6,5,7,8, Uri Tabori9,2,10, Sumedha Sudhaman1,2, Jacalyn Kelly1,2, Nicholas J Haradhvala4,5,11, Vanessa Bianchi1, Melissa Edwards1, Victoria J Forster1,2, Nuno M Nunes1,2, Melissa A Galati1,2,3, Martin Komosa1, Shriya Deshmukh12,13, Vanja Cabric14, Scott Davidson1,15, Matthew Zatzman1,16, Nicholas Light1,3,16, Reid Hayes1,15, Ledia Brunga1,15, Nathaniel D Anderson1,16, Ben Ho16, Karl P Hodel17, Robert Siddaway2, A Sorana Morrissy18,19, Daniel C Bowers20,21, Valérie Larouche22, Annika Bronsema23, Michael Osborn24, Kristina A Cole25,26, Enrico Opocher27, Gary Mason28, Gregory A Thomas29, Ben George30, David S Ziegler31,32, Scott Lindhorst33, Magimairajan Vanan34, Michal Yalon-Oren35, Alyssa T Reddy36, Maura Massimino37, Patrick Tomboc38, An Van Damme39, Alexander Lossos40, Carol Durno41,42, Melyssa Aronson41, Daniel A Morgenstern43, Eric Bouffet10, Annie Huang2,16,10, Michael D Taylor2,44, Anita Villani10, David Malkin10, Cynthia E Hawkins2,15,16,45, Zachary F Pursell17, Adam Shlien1,15,16, Thomas A Kunkel46.
Abstract
Although replication repair deficiency, either by mismatch repair deficiency (MMRD) and/or loss of DNA polymerase proofreading, can cause hypermutation in cancer, microsatellite instability (MSI) is considered a hallmark of MMRD alone. By genome-wide analysis of tumors with germline and somatic deficiencies in replication repair, we reveal a novel association between loss of polymerase proofreading and MSI, especially when both components are lost. Analysis of indels in microsatellites (MS-indels) identified five distinct signatures (MS-sigs). MMRD MS-sigs are dominated by multibase losses, whereas mutant-polymerase MS-sigs contain primarily single-base gains. MS deletions in MMRD tumors depend on the original size of the MS and converge to a preferred length, providing mechanistic insight. Finally, we demonstrate that MS-sigs can be a powerful clinical tool for managing individuals with germline MMRD and replication repair-deficient cancers, as they can detect the replication repair deficiency in normal cells and predict their response to immunotherapy. SIGNIFICANCE: Exome- and genome-wide MSI analysis reveals novel signatures that are uniquely attributed to mismatch repair and DNA polymerase. This provides new mechanistic insight into MS maintenance and can be applied clinically for diagnosis of replication repair deficiency and immunotherapy response prediction.This article is highlighted in the In This Issue feature, p. 995. ©2020 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33355208 PMCID: PMC8223607 DOI: 10.1158/2159-8290.CD-20-0790
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397